Montelukast Prescribing at HEADLANDS SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
812
Total Quantity
21.7K
NHS Cost
£1.0K
vs National Avg
+18.6%
HEADLANDS SURGERY prescribed 812 items of Montelukast over the last 12 months at a cost of £1,012 to the NHS. This is 18.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
76
Jun 2026
68
Jun 2026
72
Jun 2026
63
Jun 2026
70
Jun 2026
71
Jun 2026
59
Jun 2026
77
Jun 2026
67
Jun 2026
59
Jun 2026
68
Jun 2026
62
Prescribing Details
| Total Items | 812 |
|---|---|
| Total Quantity | 21,686 |
| Total NHS Cost | £1,012 |
| Presentations | 3 different forms |
| vs National Average | +18.6% |
Montelukast Prescribing Comparison
| This practice | 812 items |
|---|---|
| National average per practice | 685 items |
| Difference | +18.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.